Literature DB >> 16845326

Influence of melanoma inhibitory activity on transforming growth factor-beta signaling in malignant melanoma.

Tanja Rothhammer1, Anja-Katrin Bosserhoff.   

Abstract

Melanoma cells escape transforming growth factor-beta (TGFbeta)-mediated growth inhibition by expressing the Smad (mothers against decapentaplegic homolog, Drosophila) inhibitors Ski and Sno. Here, we demonstrate that melanoma inhibitory activity (MIA) influences the expression of these inhibitors. A Smad responsive reporter construct was activated after TGFbeta1 treatment in the MIA-deficient cell clones but not in the parental cell line. According to this finding, the TGFbeta target genes JunB and Id-1 showed a strong induction of expression. Additional analyses revealed that Ski and Sno, repressors of TGFbeta/SMAD signaling, are not expressed in the MIA-deficient cells but in the parental cell line HMB2 and the mock control. Further investigation showed that Ski and Sno expression might be regulated via the mitogen-activated protein kinase (MAPK)/extracellular signal-regulated kinase (ERK) signaling cascade. Treatment of HMB2 cells with a MEK inhibitor revealed a reduction of Ski and Sno expression, which leads to the conclusion that, in our melanoma cell model, Ski and Sno expression is regulated via MAPK/ERK signaling.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16845326     DOI: 10.1097/01.cmr.0000205021.17774.e7

Source DB:  PubMed          Journal:  Melanoma Res        ISSN: 0960-8931            Impact factor:   3.599


  5 in total

1.  The ERK/CREB pathway is involved in the c-Ski expression induced by low TGF-β1 concentrations during primary fibroblast proliferation.

Authors:  Ping Li; Ping Liu; Yan Peng; Zhuo-Hang Zhang; Xiao-Ming Li; Ren-Ping Xiong; Xing Chen; Yan Zhao; Ya-Lei Ning; Nan Yang; Bo Zhang; Yuan-Guo Zhou
Journal:  Cell Cycle       Date:  2018-07-23       Impact factor: 4.534

Review 2.  Resistance to transforming growth factor β-mediated tumor suppression in melanoma: are multiple mechanisms in place?

Authors:  Ahmed Lasfar; Karine A Cohen-Solal
Journal:  Carcinogenesis       Date:  2010-07-23       Impact factor: 4.944

3.  Gene expression signature associated with BRAF mutations in human primary cutaneous melanomas.

Authors:  Caroline Kannengiesser; Alain Spatz; Stefan Michiels; Alain Eychène; Philippe Dessen; Vladimir Lazar; Véronique Winnepenninckx; Fabienne Lesueur; Sabine Druillennec; Caroline Robert; Joost J van den Oord; Alain Sarasin; Brigitte Bressac-de Paillerets
Journal:  Mol Oncol       Date:  2008-01-12       Impact factor: 6.603

4.  Loss of CYLD accelerates melanoma development and progression in the Tg(Grm1) melanoma mouse model.

Authors:  Miriam Martha de Jel; Mandy Schott; Susanne Lamm; Winfried Neuhuber; Silke Kuphal; Anja-Katrin Bosserhoff
Journal:  Oncogenesis       Date:  2019-10-07       Impact factor: 7.485

5.  Insights into the Transforming Growth Factor-β Signaling Pathway in Cutaneous Melanoma.

Authors:  Carole Yolande Perrot; Delphine Javelaud; Alain Mauviel
Journal:  Ann Dermatol       Date:  2013-05       Impact factor: 1.444

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.